Associate Professor Vincent Pellegrino is a Senior Intensive Care Specialist at The Alfred Hospital and head of the ECMO Clinical Service. He has had a lead role in the development of ECMO services at The Alfred since 2003. From the ECMO CPR ICN Victoria meeting he discusses how to get patient selection and outcomes right for eCPR.
Professor Stephen Bernard is an Intensive Care Physician at The Alfred Hospital and Medical Advisor to Ambulance Victoria. His research interests include the use of therapeutic hypothermia for the treatment of neurological injury after resuscitation from out-of hospital cardiac arrest. Here he provides a presentation on recent advances in the management of refractory cardiac arrest in the out of hospital setting.
Peter Brindley - Resuscitation: What’s the PointSMACC Conference
Resuscitation- what's the point.
Cardiopulmonary resuscitation (CPR) is unique as the only medical intervention performed on anyone without explicit contrary documentation. Therefore, CPR need to be understood in terms of societal expectations, legal mandates and professional duties. We also need to understand not just the the likelihood of survival, but also the likelihood of disability and the cost (both literally and figuratively) to patients, healthcare workers, and to an already stretched healthcare system. Even the term 'resuscitation' means different things to different people...and that's before we even wade into such terms as 'autonomy', 'paternalism' and 'patient-focused care'.
In short, doctors, nurses patients and families can no longer shy away from discussing CPR: it's time to talk. It can be a remarkable way to prevent premature death, it can also squander finite resources and be the beginning of a terrible ordeal for frail patients and frazzled families.
Slides for a talk by Professor David Pilcher about Lung Transplantation. The talk is aimed at the general intensivist and intensive care trainees and focuses on general and post-operative management. It is available as an episode of The INTENSIVE Podcast here:
Peter McCanny is part of the LearnECMO team. In this podcast he explains some of the background and history of ECMO CPR, what evidence there is to support its use and where we're heading in the future.
Professor Stephen Bernard is an Intensive Care Physician at The Alfred Hospital and Medical Advisor to Ambulance Victoria. His research interests include the use of therapeutic hypothermia for the treatment of neurological injury after resuscitation from out-of hospital cardiac arrest. Here he provides a presentation on recent advances in the management of refractory cardiac arrest in the out of hospital setting.
Peter Brindley - Resuscitation: What’s the PointSMACC Conference
Resuscitation- what's the point.
Cardiopulmonary resuscitation (CPR) is unique as the only medical intervention performed on anyone without explicit contrary documentation. Therefore, CPR need to be understood in terms of societal expectations, legal mandates and professional duties. We also need to understand not just the the likelihood of survival, but also the likelihood of disability and the cost (both literally and figuratively) to patients, healthcare workers, and to an already stretched healthcare system. Even the term 'resuscitation' means different things to different people...and that's before we even wade into such terms as 'autonomy', 'paternalism' and 'patient-focused care'.
In short, doctors, nurses patients and families can no longer shy away from discussing CPR: it's time to talk. It can be a remarkable way to prevent premature death, it can also squander finite resources and be the beginning of a terrible ordeal for frail patients and frazzled families.
Slides for a talk by Professor David Pilcher about Lung Transplantation. The talk is aimed at the general intensivist and intensive care trainees and focuses on general and post-operative management. It is available as an episode of The INTENSIVE Podcast here:
Peter McCanny is part of the LearnECMO team. In this podcast he explains some of the background and history of ECMO CPR, what evidence there is to support its use and where we're heading in the future.
Mervyn Singer discusses the use of biomarkers in critical care.
Multiple biomarkers - physiological, biochemical, biological - can prognosticate early in critical illness, even in the ED.
These biomarkers are numerous - lipids, progesterone, troponin, thyroid stimulating hormone, inflammatory cytokines, mitochondrial dysfunction… so on and so forth!
Prognostication can happen as early as the Emergency Department.
Studies from the States have found high levels of inflammatory cytokines can predict death, separately from clinical presentation. Therefore, we can predict when critically ill patients are destined to die. So, does this mean that we are just prolonging the life of those destined to die in critical care? Perhaps.
Mervyn discusses this being the possible reason for many failed ICU studies. Concurrently, the only progress in critical care in the past 20 years may be due only to less iatrogenic harm.
Furthermore, he explains his experiments with rats demonstrating the use of cardiovascular parameters, cytokines, troponins and even cholesterol being accurate prognostic biomarkers.
Then, Mervyn goes on to identify the use of steroids in sepsis. He talks about research that demonstrates a benefit to steroid use, but only in those patients predicted to die using the aforementioned biomarkers. This could be a key to selecting an appropriate patient group to allocate a specific treatment too.
Furthermore, we examine treating sepsis with beta blockers. Giving beta blockers to everyone has no effect at best and a harmful effect at worst. However, giving beta-blockers to those who were predicted to die conferred benefit!
In conclusion, we can predict outcome early in disease. This may allow better selection of patients for certain treatments! We thus need to adopt a completely different strategy for such patients predetermined to die. This also applies to trial design, especially where survival is the endpoint.
For more like this, head to our podcast page. #CodaPodcast
CPR with ECLS vs conventional CPR in IHCASun Yai-Cheng
Cardiopulmonary Resuscitation with Assisted Extracorporeal Life-Support versus Conventional Cardiopulmonary Resuscitation in Adults with In-Hospital Cardiac Arrest
Lancet 2008; 372:554-561
Understanding the Translational Value of PV Loops from Mouse to ManInsideScientific
In this exclusive webinar sponsored by Millar, Dr. Navin Kapur, Assistant Professor and Assistant Director of the Interventional Cardiology Center at Tufts Medical Center, discusses how PV loop data can translate over from mouse to man and provide a confident approach to evaluating drug studies, device validation and treatments outcomes. Hemodynamics and measurements of cardiac function from the research bench-top are presented along with findings from the clinical research settings. Furthermore, Dr. Kapur provides perspective on how PV Loops can be used as a tool for the interventional cardiologist and during the evaluation of advanced heart failure.
Dr. Navin Kapur's research interests include the molecular basis of cardiac fibrosis, transforming growth factor-beta signaling in cardiac fibroblasts, and novel imaging modalities of myocardial perfusion.
ICN Victoria presents Professor Oliver Cornely, Professor of Internal Medicine and Director for Clinical Trials at University Hospital, Cologne, Germany. His research interests include invasive fungal diseases in haematology/oncology and in the ICU setting. Dr Cornely is also a clinical infectious diseases consultant at the University Hospital of Cologne.
Professor Cornely gives an entertaining talk on the pervasiveness, invasiveness, diagnosis and treatment of fungal infections in ICU patients.
Mervyn Singer discusses the use of biomarkers in critical care.
Multiple biomarkers - physiological, biochemical, biological - can prognosticate early in critical illness, even in the ED.
These biomarkers are numerous - lipids, progesterone, troponin, thyroid stimulating hormone, inflammatory cytokines, mitochondrial dysfunction… so on and so forth!
Prognostication can happen as early as the Emergency Department.
Studies from the States have found high levels of inflammatory cytokines can predict death, separately from clinical presentation. Therefore, we can predict when critically ill patients are destined to die. So, does this mean that we are just prolonging the life of those destined to die in critical care? Perhaps.
Mervyn discusses this being the possible reason for many failed ICU studies. Concurrently, the only progress in critical care in the past 20 years may be due only to less iatrogenic harm.
Furthermore, he explains his experiments with rats demonstrating the use of cardiovascular parameters, cytokines, troponins and even cholesterol being accurate prognostic biomarkers.
Then, Mervyn goes on to identify the use of steroids in sepsis. He talks about research that demonstrates a benefit to steroid use, but only in those patients predicted to die using the aforementioned biomarkers. This could be a key to selecting an appropriate patient group to allocate a specific treatment too.
Furthermore, we examine treating sepsis with beta blockers. Giving beta blockers to everyone has no effect at best and a harmful effect at worst. However, giving beta-blockers to those who were predicted to die conferred benefit!
In conclusion, we can predict outcome early in disease. This may allow better selection of patients for certain treatments! We thus need to adopt a completely different strategy for such patients predetermined to die. This also applies to trial design, especially where survival is the endpoint.
For more like this, head to our podcast page. #CodaPodcast
CPR with ECLS vs conventional CPR in IHCASun Yai-Cheng
Cardiopulmonary Resuscitation with Assisted Extracorporeal Life-Support versus Conventional Cardiopulmonary Resuscitation in Adults with In-Hospital Cardiac Arrest
Lancet 2008; 372:554-561
Understanding the Translational Value of PV Loops from Mouse to ManInsideScientific
In this exclusive webinar sponsored by Millar, Dr. Navin Kapur, Assistant Professor and Assistant Director of the Interventional Cardiology Center at Tufts Medical Center, discusses how PV loop data can translate over from mouse to man and provide a confident approach to evaluating drug studies, device validation and treatments outcomes. Hemodynamics and measurements of cardiac function from the research bench-top are presented along with findings from the clinical research settings. Furthermore, Dr. Kapur provides perspective on how PV Loops can be used as a tool for the interventional cardiologist and during the evaluation of advanced heart failure.
Dr. Navin Kapur's research interests include the molecular basis of cardiac fibrosis, transforming growth factor-beta signaling in cardiac fibroblasts, and novel imaging modalities of myocardial perfusion.
ICN Victoria presents Professor Oliver Cornely, Professor of Internal Medicine and Director for Clinical Trials at University Hospital, Cologne, Germany. His research interests include invasive fungal diseases in haematology/oncology and in the ICU setting. Dr Cornely is also a clinical infectious diseases consultant at the University Hospital of Cologne.
Professor Cornely gives an entertaining talk on the pervasiveness, invasiveness, diagnosis and treatment of fungal infections in ICU patients.
Jason Maclure is deputy director of Intensive Care at the Alfred Melbourne. He has strong interests in analgesia and sedation, respiratory failure, ventilation, HFOV and ECMO. From an ICN Victoria 2016 meeting on ECMO CPR he discusses the development of the eCPR protocol at the Alfred.
Claire Cattigan is an Intensivist and Deputy Director of ICU at The University Hospital Geelong. She is interested in the management of paediatric patients in mixed ICUs and gives a fascinating talk on the challenges and rewards of introducing paediatric patient care into a general, adult intensive care unit.
Shoes, Sex and Secrets: Stress in EMS -Ashley liebig SMACC Conference
A pair of outrageously high heels next to a pair of tattered combat boots, set the stage for Ashley’s talk on the stress of PHARM.
Ashley draws on lessons learned in combat to support her theory of mental health survival.
She emphasizes the importance of critical incident recognition, response and elimination of stigma associated with seeking help.
A clinical overview of four important Australian envenomings: Redback spider, Funnelweb spider, Box jellyfish and Irukandji Syndrome. The talk was given at the Bedside Critical Care 2012 conference in the Whitsunday Islands.
Are You as Good as You Think?
Simon Carley has us asking ourselves some confronting questions about our abilities in his SMACC Chicago talk ‘Are You as Good as You Think?’. Carley has us delve into our confidence, competencies and whats makes for a good self learning environment.
Initially Carley asks us how good we think we are at driving? He then sites studies of Australian and European driver responses, of which 93% of Aussies and 69% europeans rated themselves as above average drivers. Carley uses this example to suggests that, as individuals we are not particlarly good at rating ourselves, and inexperienced people tend to rate themselves more highly than experienced one - Illusory Superiority Cognitive Bias. Carley asks since you can’t have awesome without average... How do we measure ourselves?. He offers us the following tools and processes to establish better self learning and teaching processes, such as;
Reflection Diaries - revisit it (clinically and physically), follow up.
Peer reviews: 1:1 feedback doesn’t work. It needs to planned with clear goals and objectives such as;
Clarify expectations
review logistics
focus lens
plan feedback
observe event (i.e teaching)
debrief and action
Clinical Feedback
Follow up - not just the exceptionally sick patients, but follow up with the routine ones.
Build Peer Reviews into your practice.
Carley finishes by asking us to choose on of the items below and commit ourselves to making happen within the month.
I am going to …
Organise Trainee Feedback
Focused 360 Assessment
Keep a Patient/Teaching Diary
Be Peer Reviewed
Reflect
Develop Team Feedback
Follow up with Patients
Something Else
Nothing I am already Awesome!
What have you committed too?
Professor Andrew Davies is an Intensivist working at Peninsula Health in Melbourne. He has performed clinical research in the field of critical care for 20 years, as a participating investigator in over 50 studies (mostly clinical trials), predominantly in the areas of critical care nutrition, mechanical ventilation and acute lung injury and severe sepsis. He is a past Vice Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) with a special interest in nutrition in the ICU, and is a past Chair of the Australian and New Zealand Society of Parenteral and Enteral Nutrition (AuSPEN).
In this talk, Professor Davies tackles the often overlooked aspect of nutrition in the ICU and it’s potential benefits for our patients.
Hazel Talbot gives her insights from working in neonatal and paediatric retrieval.
She delivers her talk with all the passion and dedication that she brings to her work as a neonatal and paediatric transport consultant.
Equipment failure, rapidly deteriorating children and miscommunication are all common challenges that Hazel and her team encounter in their line of work. This is on top of the challenge of caring for neonates and children.
How are children different? They differ in physiology, in disease profiles and even the way they make clinicians feel!
In this talk, Hazel focuses on physiology and disease. The large majority of young deaths in the UK, where Hazel works, are neonates – under 28 days old.
50% of these deaths are due to perinatal diseases. These include congenital malformations, prematurity, sepsis, and congenital heart conditions.
Children are small adults. Small airways, small necks, small lungs. Babies however are not small children. They use the majority of their physiological ability to survive.
When they breath they use most of their diaphragm, compared with an adult who will only use a small proportion. This leaves babies without much reserve. They have a high metabolic rate, and neonates have a right heart dominance with an inability to change their stroke volume.
Hazel urges you to consider this when faced with a sick baby. When thinking about neonatal and paediatric retrieval, Hazel has some key points. Practice, anticipation and knowing your environment and equipment is key to a success outcome.
Hazel drives this message home with a case presentation. This example highlights not only Hazel’s skill and knowledge, but also her ability of communication, leadership, and intuition.
Join Hazel as she gives an insight into her amazing work in neonatal and paediatric retrieval. Come along as she discusses her experiences and tells you how to ward of the Evil Transport Fairy!
For more like this, head to our podcast page. #CodaPodcast
Selective Aortic Arch Perfusion -
Summary by: Jim Manning
Selective Aortic Arch Perfusion (SAAP) is an endovascular-extracorporeal perfusion resuscitation technique designed specifically to treat cardiac arrest. SAAP involves the blind insertion of a large-lumen balloon occlusion catheter into the descending thoracic aortic arch via a femoral artery. With the SAAP catheter balloon inflated in the thoracic aorta, the heart and brain are relatively isolated for resuscitative perfusion through the SAAP catheter lumen with an oxygen-carrying fluid (such as blood, hemoglobin-based oxygen carrier or fluorocarbon emulsion). SAAP promotes restoration of spontaneous circulation (ROSC) by the heart while protecting the brain from further ischemic insult. SAAP can be used to treat both hemorrhage-induced traumatic cardiac arrest and medical, non-traumatic cardiac arrest.
In traumatic cardiac arrest, SAAP provides the combination of (1) thoracic aortic balloon occlusion for control of hemorrhage below the diaphragm, (2) rapid volume replacement in hemorrhage-induced hypovolemia to restore normovolemia and (3) perfusion of the heart and brain in an effort to achieve ROSC. SAAP also allows titration of small doses of intra-aortic adrenaline or other medications to achieve ROSC.
In medical cardiac arrest, SAAP catheter balloon occlusion of the thoracic aorta limits the distribution of oxygenated perfusate toward the heart and brain. Since medical cardiac arrest patients are not typically hypovolemic, SAAP with an exogenous oxygen-carrier is a volume loading intervention that can only be used for a short time period (5-10 min). If ROSC is not achieved with the limited volume of exogenous oxygen-carrier, femoral venous access during initial SAAP infusion allows venous blood withdrawal for continued SAAP support to promote ROSC without further volume loading (autologous blood SAAP or, essentially, aortic arch ECMO). Intra-aortic adrenaline and anti-reperfusion agents can also be used. Even if ROSC is not rapidly achieved, SAAP serves as a bridge that limits hypoperfusion until cannulation for full body ECMO can be achieved.
When to Transfuse in Acute Brain Injury: Oli Flower & Simon FinferSMACC Conference
Simon Finfer argues that the transfusion threshold should be 70 g/L. Simon first raises the Choosing Wisely Guidelines for Critical Care.
These state that one should not transfuse red blood cells in haemodynamically stable patients with a haemoglobin concentration of greater than 70g/L.
He continues to discuss the application of this specifically to patients with an acute brain injury. In doing so he will talk about evidence generally and how one must approach the use of evidence in specific patient subgroups.
Simon continues by raising further research to justify his position.
Oli Flower on the other hand will take the position that the transfusion trigger should be 90g/L. He makes the point that this is the easy position to take. Essentially, he is just explaining why the critical care community does what it does!
As Oli explains, haemoglobin plays a pivotal role in providing oxygen to tissue. In the case of a brain injury, to prevent further injury, one must ensure continued supply of oxygen to said tissue.
Oli will lean on animal studies, human studies as well as trial data to support his position. The transfusion trigger is remarkable heterogeneous around the world and even within individual institutions and this drives critical care professionals mad.
So surely there must be a “right” number. Unfortunately, there is not, which is where understanding all the relevant aspects to the argument becomes important.
Join Oli and Simon as they debate on this important issue.
When to Transfuse in Acute Brain Injury: Oli Flower & Simon Finfer
For more like this, head to our podcast page. #CodaPodcast
Shay McGuinness talks about what ECMO is, the history of its use in New Zealand and how their ECMO retrieval system works there. This was recorded live at the inaugural ICN NZ meeting, with support from ANZICS NZ.
Andy Sloas - Are we Masters of the Paediatric Airway?SMACC Conference
One of the many things that we, as intensivists or emergency physicians, do better than anyone in the business is obtain the emergent airway. We are usually introduced to our patients on the worst days of their lives and even though we may sometimes wish for it, we do not have the option to reschedule our intubations. Smashed, bloody, distorted, edematous airways secondary to trauma, anaphylaxis, and GI bleeds are the commonality not the exception. We manage those airways routinely with nary a complaint or even a hither for a better look at the glottis than what we can obtain. We often feel lucky to even get a glimpse of the arytenoids much less something that actually resembles normal laryngeal anatomy. Personally, if I knew that I would need to be intubated today, that my airway would be a bloody, edematous, traumatic mess and there was only chance for one person to take a shot at placing the tube, then I would pray to God that the last face I saw before the Roc and Ketamine pushed me asunder was the familiar grill of one of my EM/critical care colleagues. Who better to bet all my chips on then someone who deals with the most difficult airways on the face of the planet as part of their daily routine? The EM doc or critical care provider can not only get that airway, but is so relaxed about it that they will often casually check on the patient in the next bed before and after the intubation. That’s the confidence I’m looking for when it comes to the fast-paced life and death world of emergency airway. Now put a child’s life on the line. Are you ready to intubate what was a perfectly healthy three year old two hours before trauma threatened their life and placed their airway in your hands? You will be...
Andrew Sloas DO, RDMS, FACEP, FAAEM, FAAP Editor-in-Chief: The PEM ED Podcast www.pemed.org
Medicine for Mars - Kevin Fong
Summary by: Kevin Fong
Kevin Fong is an astrophysicist, astronaut and anaesthetist who gives an incredibly entertaining talk about human space exploration and our dreams of a manned mission to MARS. This is a mission that stands on the boundary between science fiction and science fact. A mission that would be a minimum of 1000 days in length and which would be twice as long as any previous manned space mission.
Fong focuses on the the incredibly destructive effects of such prolonged weightlessness on the human body. He outlines the somewhat predictable effects of this on the muscles and bones, but surprises us with the changes in vestibular balance, linear acceleronomy, baroreceptor calibration and probably most frighteningly the psychological effects of prolonged isolation in space. Despite considerable work in the area of human adaptation for space and the ongoing development of counter-measures these physiological challenges remain largely unsolved.
In essence Fong explains, to overcome the detrimental physiological effects of prolonged weightlessness engineers need to design a craft capeable of generating 1G of gravitational force to mimick earth’s gravity. This could require a craft the size of the London EYE rotating four times per minute. Perhaps if this can be achieved, astronauts might arrive at MARS after 30 months in space in a physcial state capeable of allowing them to stand upright and walk from the landing craft.
Trish Woods guides you through some clinical pearls in the intensive care management of neonates.
The complex physiology of the transitioning required in the journey from foetal life to neonatal presents many challenges and scary moments.
Trish helps you to navigate these challenges and to unlock the key to providing quality neonatal intensive care.
Many things can go wrong in the neonatal period as babies transition to life in the real world. Trish highlights her thoughts on the use of positive end expiratory pressure (PEEP), how deep to intubate, when to clamp the cord and the use of ultrasound.
When babies arrive early their lungs can be full of meconium or fluid. Due to this, Trish recommends using PEEP – without which there is distal airway collapse and fluid accumulation.
Aeration of the lungs is vital. To this end, how deep should intubation be aimed? The depth may not be overly important. This is because regional lung aeration triggers widespread, global increase in pulmonary blood flow.
There is little definitive evidence to guide clinicians on when to clamp the cord – early or late. Trish recommends considering the physiology of clamping the cord.
After clamping the cord there is a massive drop in cardiac output. Ventilatory support will turn this around – something to remember.
In a compromised baby, perhaps we should aim to clamp the cord sooner and then initiate ventilation.
Finally, Trish highlights the utility of ultrasound. Viewing the heart and lungs provides crucial information for the clinician.
Furthermore, Trish discusses actively looking for aeration, collapse, consolidation and pneumothorax in the lungs and thorax.
Overall, don’t forget the essentials. Trish reminds you to keep life sweet, warm, and tempting and help neonates to transition into the big world.
Neonatal Intensive Care: Trish Woods
For more like this, head to our podcast page. #CodaPodcast
Managing the Transected Airway by Georgie HarrisSMACC Conference
The management of the transected airway is frightening because it is a rare airway emergency and one that does not fit the usual plan A,B,C airway management algorithms. An approach is presented which considers two principal anatomical distinctions for injuries both above and below the cricoid cartilage.
Secondly, the mechanism of injury is classified according to whether it is either penetrating or blunt trauma. Finally the airway management urgency is described according to either an immediate or semi-urgent approach being required. These three approaches, the location of the injury relative to the cricoid, the mechanism of the injury and thirdly, the urgency of the airway intervention required are then applied together to provide a guide to management of the transected airway.
Penetrating injuries to the neck is a great summary of how to assess and manage neck wounds from lacerations to the airway to gunshot wounds. The talk covers relevant anatomy, the zones of the neck and how to investigate vascular, tracheal and oesophageal injuries. A comprehensive understanding of the relevat anatomy is essential to recognising associated injury patterns. The improvements in the accuracy of helical CTA scans has meant that the delineation of the zones of the neck has become less relevant to the further investigation and management of pemetrating neck wounds. Oesphageal injuries remain difficult to detect and require a high level of clinical suspicion to identify these.
Steve Bernard speaks at a meeting on 4/2/14 in Sydney on the reality of ECMO CPR at The Alfred in Melbourne, Victoria, and the upcoming CHEER study.
Exciting times!
See Intensive Care Network for the talk and more.
PowerPoint presentation on ECMO (Extracorporeal Membrane Oxygenation). Part 2 focuses on Monitoring ECMO patients
Ventilatory strategies, Sedation and pain control, Weaning, Complications and recent advances in ECMO. For better understanding please have a look at ECMO part 1 before going through part 2.
Slides for a talk by Vincent Pellegrino (ECMO Director at The Alfred ICU) on ECPR. For videocast and audio only versions of this talk go to the RAGE podcast (http://ragepodcast.com/ecpr-vincent-pellegrino/) or The Alfred ICU's INTENSIVE blog (http://intensiveblog.com/ecpr-vin-pellegrino/).
Adult Orthopedic Imaging Mastery Project - Pelvic Ring FracturesSean M. Fox
Drs. Carrie Bissell, Aaron Fox, and Kendrick Lim are Emergency Medicine Residents at Carolinas Medical Center and are interested in emergency medicine and medical education. With the guidance of Dr. Michael Gibbs, a notable Professor of Emergency Medicine and Dr. Laurence Kempton, an Orthopedic Surgeon, they aim to help augment our understanding of emergent imaging. Follow along with the EMGuideWire.com team as they post these educational, self-guided radiology slides that focus on Adult Orthopedic cases. This set will cover:
- Pelvic Ring Fractures
Improving survival from Sudden Cardiac Arrest – can it really work?Haydn Drake
Gary Strong's presentation at the Paramedics Australasia NZ CPD event in Auckland on 3 July 2013.
Gary is the Programme Leader BHSc Paramedic at Whitireia Polytechnic, and prior to that was the Education & Training Manager at Wellington Free Ambulance.
Prior to coming to New Zealand, Gary was the Paramedic Clinical Lead at the Great Western Ambulance Service, an Education and Development Tutor at the Gloucestershire Ambulance Service, and worked as a paramedic with the West Midlands Ambulance Service NHS Trust.
PRMC Case Study - "No Distress Noted" - One Patient's Perspective on Peterson...Cathy Learoyd
A Patient's life is jeopardized by missed diagnoses and breakdowns in communications. Patient's mortality is compared to research studies to show how mortality and therefore hospital ranking could be improved by the recommendations presented.
The Top 10 Resuscitation Headlines and Controversies: And How To Read Past Th...Rommie Duckworth
We’ve all heard controversies about cardiac resuscitation. “Use the right medications.”, “Medications don’t matter.”, “Airway first!”, “Don’t worry about the airway!” It is confusing for EMS professionals to sort out exactly what they’re supposed to do. Taking a look at the Top Ten Headlines for cardiac resuscitation, this program evaluates the strength of the science behind each recommendation as well as how they might be implemented in different EMS systems. Getting past the “Headlines,” attendees will return home well-equipped to open up discussions about optimizing EMS cardiac arrest resuscitation in their systems beyond “I read this study once” or “This is what the algorithms say now.”
Associate Professor Neil Orford is an intensive care specialist and Director of Intensive Care at University Hospital Geelong. Neil is the clinical lead for the i-Validate program. In this podcast he discusses this collaboration between Barwon Health and Deakin University which aims to improve patient-centred end-of-life care through training in clinical communication.
Associate Professor Sue Berney is head of physiotherapy at Austin Health. She has a passion for research into patient outcomes in intensive care. Here she discuses cognitive dysfunction post critical illness.
Kimberley Haines is a senior ICU physiotherapist and the Allied Health Research Lead at Western Health. Her academic research focusses on the long term progress of ICU survivors. Here she discusses the developing puzzle of ICU outcomes.
Professor Rinaldo Bellomo is an Intensivist at the Austin Hospital in Melbourne. He is Professor of Medicine at Melbourne University, and Honorary Professor of Medicine at Monash University, Melbourne and The University of Sydney.
He is one of the most eminent researchers in Intensive Care Medicine today and has been named one of the most influential scientific minds of our time.
In this thought-provoking talk Professor Bellomo discusses glycemic control of critically ill diabetic patients in the ICU.
David Anderson is an intensivist and medical donation specialist at the Alfred Hospital Melbourne. From a 2016 ICN Victoria meeting he discusses the coming epidemic of dementia and how its coming to an intensive care near you.
Huy Tran is a lab and clinical haematologist at Peninsula Health. He has research interests in haemostasis and thrombosis and is a member of the Australasian committee for anticoagulation reversal. Here he presents on the new oral anticoagulants and what can be done when they cause critical bleeding
Dr Sachin Gupta an intensivist at Peninsula Health presents on the difficulties we currently face in predicting bleeding and how this might change in the future.
Dr Steve McGloughlin is an intensivist at the Alfred Hospital. He is also an infectious diseases specialist and maintains both clinical and research interests in infections in critically ill patients. Here he discusses the ongoing primacy of antibiotics in intensive care and our continuing battle with antibiotic resistance
ICN Victoria presents Dr Andy Buck, Emergency Physician and Director of the well regarded Emergency Trauma Management course, talking the how's, why's and what's of teaching Gen Y doctors.
ICN Victoria presents Dr Andy Buck, Emergency Physician and Director of the well regarded Emergency Trauma Management course, talking on managing the resuscitation room, a teamwork approach to CRM.
Dr Andrew Davies, Intensivist at Frankston Hospital, talks on burnout for intensivists, how to prevent it, what to do if you get there, and simple tips for living a more productive life generally. Inspiring, introspective and pragmatic.
ICN Victoria presents Professor Jack Iwashyna, giving a thought provoking talk on how we may better use data from ANZICS large RCTs to guide management of our critically ill patients.
ICN Victoria presents Dr Aiden Burrell talking on the diagnosis, clinical features and treatment of right ventricular failure for the Intensive Care Specialist
ICN Victoria presents Dr Aiden Burrell from the Alfred Hospital in Melbourne, talking on ways to optimise your non-clinical time as an intensive care trainee
ICN Victoria presents Dr Andrew Hilton, Intensivist at the Austin Hospital in Melbourne, talking on the use of Echocardiography to evaluate the septic heart. Recorded at our November 2014 ICN Victoria meeting.
ICN Victoria presents Dr Andrew Hilton, Intensivist at the Austin Hospital in Melbourne, talking on the use of ultrasound in ICU to evaluate and treat lung pathology. Recorded at our November 2014 ICN Victoria meeting.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Pellegrino - ECMO CPR - Getting it Right
1. The Alfred Intensive Care Unit, Melbourne, Australia
The use of VA ECMO following Cardiac Arrest
E-CPR
Vincent Pellegrino
Aidan Burrell
Steven Bernard
Richard Lin
Deirdre Murphy
Lloyd Roberts
Jayne Sheldrake
Carol Hodgson
D. Jamie Cooper
Vinodh Nanjayya
Bishoy Zachary
Daniel Brodie
2. The Alfred Intensive Care Unit, Melbourne, Australia
Cardiac
Arrest
VA ECMO Survival
Condition Treatment Outcome
Assessing the impact of E-CPR
3. The Alfred Intensive Care Unit, Melbourne, Australia
Assessing the impact of E-CPR
Out Hospital
CA
VA ECMO Survival
Condition Treatment Outcome
In Hospital
CA
+ROSC +CS
+ROSC +CS
- ROSC
- ROSC
Neuro
Cost
QOL
Organ
Donation
Unsupportable
4. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
Alfred Hospital - Melbourne
ECMO commenced within 30
minutes of a cardiac arrest
which has been associated
with c-CPR for greater than
10 minutes or has rendered
the patient unconscious
Based on the CA
definition for therapeutic
hypothermia
i.e. the CA has contributed to the
patient neurological outcome
5. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
Taipei, Taiwan JACC 2003
“Briefly, patients were recruited into the
ECPR group only if they: 1) were in cardiac
arrest that necessitated external or open-
chest cardiac massage and a large amount
of epinephrine (5 mg) during CPR; 2) could
not be returned to spontaneous circulation
within 10 to 20 min; and 3) subsequently
received ECMO in the hospital”
no ROSC ROSC+
6. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
Japan, SAVE-J 2014
7. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
ELSO: Ann Thor Surg 2009
“The registry defines E-CPR as the following:
“extracorporeal life support (ECLS) used
as part of initial resuscitation from cardiac
arrest. Patients who are hemodynamically
unstable and placed on ECLS without cardiac
arrest are not considered E-CPR” [1].
no ROSC ROSC+
8. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
How to proceed … ?
Out of Hospital
9. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
How to proceed … ?
In Hospital
10. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the Condition:
•Cardiac Arrest Definitions
•Patient Diagnostic Groups
•Cardiac Arrest Rates
How to proceed … ?
12. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Defining the condition
Cardiac arrest of greater than
20 min (conventional CPR)
Sub-classifications
• Pathological Classification
• +/- ROSC
• + out-of-hospital
• (initial rhythm)
Diagnostic groups
13. The Alfred Intensive Care Unit, Melbourne, Australia
Patient Population (Who?)
Exclusion Criteria
These will vary greatly from
centre to centre
14. The Alfred Intensive Care Unit, Melbourne, Australia
Outcomes from E-CPR
(What seems to work?)
SAVE-J study
Propensity Matching
ELSO
Risk Prediction
-Biomarkers
Organ Donation
Strongest trial design
for E-CPR
15. The Alfred Intensive Care Unit, Melbourne, Australia
Out of Hospital Cardiac Arrest Survival
and ECMO
18. The Alfred Intensive Care Unit, Melbourne, Australia
Outcomes from E-CPR
(What seems to work?)
SAVE-J study
Propensity Matching
ELSO
Risk Prediction
-Biomarkers
Organ Donation
19. The Alfred Intensive Care Unit, Melbourne, Australia
Outcomes from E-CPR
(What seems to work?)
SAVE-J study
Propensity Matching
ELSO
Risk Prediction
-Biomarkers
Organ Donation
21. The Alfred Intensive Care Unit, Melbourne, Australia
Outcomes from E-CPR
(What seems to work?)
SAVE-J study
Propensity Matching
ELSO
Risk Prediction
-Biomarkers
Organ Donation
Future Models are essential
1. Age
2. First monitored rhythm
3. Time to ECMO
4. Biomarkers (early
lactate)
5. No/minimal physiological data
22. The Alfred Intensive Care Unit, Melbourne, Australia
Conclusions
E-CPR has strong physiological and evidence base to
support its use and ongoing development
Large database with accurate data to build risk
prediction models to assess performance
•allow better case selection
•allow comparison between services
•allow comparison between different treatments
Only one thing better than successfully treating a
cardiac arrest case with ECMO……